Concepedia

Harvey Brandwein

HB

30

Publications

1.4K

Citations

20

H-Index

1981

Active since

Affiliations

Pall Corporation (United States)(Current)

UPMC Hillman Cancer Center

Stanford University

Palo Alto Veterans Institute for Research

University of Virginia

Harvey Brandwein is an author at Pall Corporation (United States) specializing in medicine, immunology, and microbiology.

Top concepts

MedicineImmunologyMicrobiologyImmunotherapyInfection ControlCell BiologyBioanalysisEngineeringBiochemistryHealth

Publications per year

1981–2012

30

Publications

30

Immunohistochemical localization of guanylate cyclase within neurons of rat brain.

Marjorie A. Ariano, John Lewicki, Harvey Brandwein et al. · Proceedings of the National Academy of Sciences · 1982 · 202 citations · Full text

Immunohistochemical Localization, Neurotransmission, Cellular Neurobiology +18

Meeting Lot-Size Challenges of Manufacturing Adherent Cells for Therapy

Jon A. Rowley, Eytan Abraham, Andrew Campbell et al. · 2012 · 142 citations

Tissue Engineering, Cell Therapy, Lot-size Challenges +27

Reversible inactivation of guanylate cyclase by mixed disulfide formation.

Harvey Brandwein, John Lewicki, Ferid Murad · Journal of Biological Chemistry · 1981 · 131 citations · Full text

Practical guidelines for process validation and process control of white cell‐reduced blood components: report of the Biomedical Excellence for Safer Transfusion (BEST) Working Party of the International Society of Blood Transfusion (ISBT)

Larry J. Dumont, Paolo Rebulla, Harvey Brandwein · Transfusion · 1996 · 120 citations

IRX-2, a novel immunotherapeutic, protects human T cells from tumor-induced cell death

Malgorzata Czystowska, Jinhua Han, Mirosław J. Szczepański et al. · Cell Death and Differentiation · 2009 · 75 citations · Full text

Cancer Immunosurveillance, Immunology, Tumor-induced Cell Death +8

Rows per page

1–5 of 30